Celentyx Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
2ndary - Private
Celentyx General Information
Description
Provider of human immune cell assay services intended to understand the effect of small molecules and biological candidates on the human immune system. The company offers an analysis of drug action on human immune cells, bolsters the progression of immuno-oncology therapies, provides access to patient and healthy donor samples for in-depth analysis, and accelerates therapeutic discoveries in immunology, enabling physicians to detect the human system at the levels of resolution.
Contact Information
Website
www.celentyx.comCorporate Office
- Birmingham Research Park
- 97 Vincent Drive
- Birmingham B15 2SQ
- England, United Kingdom
Corporate Office
- Birmingham Research Park
- 97 Vincent Drive
- Birmingham B15 2SQ
- England, United Kingdom
Celentyx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 01-Feb-2021 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2021 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 12-Dec-2007 | Completed | Generating Revenue | |||
| 3. Grant | 13-Dec-2006 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2004 | Completed | Startup |
Celentyx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary 1 | ||||||||
| Ordinary |
Celentyx Patents
Celentyx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2009502768-A | Acupuncture | Inactive | 22-Jul-2005 | ||
| AU-2006271377-A1 | Novel epilepsy treatment | Inactive | 22-Jul-2005 | ||
| CA-2616141-A1 | Novel epilepsy treatment | Inactive | 22-Jul-2005 | ||
| EP-1906959-A1 | Novel epilepsy treatment | Inactive | 22-Jul-2005 | ||
| GB-0515090-D0 | Novel epilepsy treatment | Inactive | 22-Jul-2005 | A61K31/46 |
Celentyx Signals
Celentyx FAQs
-
When was Celentyx founded?
Celentyx was founded in 2004.
-
Where is Celentyx headquartered?
Celentyx is headquartered in Birmingham, United Kingdom.
-
What is the size of Celentyx?
Celentyx has 13 total employees.
-
What industry is Celentyx in?
Celentyx’s primary industry is Drug Discovery.
-
Is Celentyx a private or public company?
Celentyx is a Private company.
-
What is Celentyx’s current revenue?
The current revenue for Celentyx is .
-
How much funding has Celentyx raised over time?
Celentyx has raised $121K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process